Aorto-iliac angioplasty and stenting (2023 – CME) – online course
Description
Authors: D. Tsetis and M. Tsitskari
Reviewers: P. Gkoutzios, S. Hopf-Jense, C. Nice, B. Peynircioglu, and T. Pfammatter.
This course corresponds to chapter 2.2.1.1.1 Peripheral arterial disease in the European Curriculum and Syllabus for IR.
Abstract
Atherosclerotic disease is a common medical condition that is generally underdiagnosed and undertreated. The aorto-iliac arteries constitute a common anatomic site for atherosclerotic disease, accounting for approximately one-third of all symptomatic peripheral artery disease. The majority of patients are asymptomatic. Symptomatic patients may present with intermittent claudication or critical limb ischaemia in the form of either tissue loss (ischaemic foot ulcers or gangrene) or ischaemic rest pain. A range of surgical and endovascular treatment options are available. Open surgery has historically been the gold-standard treatment. With increasing experience, and advances in devices and imaging, less invasive endovascular treatments have expanded to treat even more complex cases. Endovascular treatment has good safety and long-term efficacy with decreased morbidity, complications and costs compared with open surgical procedures. Both percutaneous transluminal angioplasty (PTA) and stenting are commonly used endovascular treatment options for iliac artery occlusive disease. A number of new balloon and stent technologies can be utilised with high long-term patency, but comparative data on these treatment strategies and in more complex lesions are lacking since both techniques showed high patency rates. As a general consensus, a stenotic or occlusive lesion of the aortoiliac artery can be treated successfully by PTA and provisional stenting. Alternatively, primary stenting may be used for more complex aorto-iliac lesions. However, there is limited evidence to prove which endovascular treatment strategy is superior for different types of stenotic/occlusive lesions of the iliac arteries.
Learning objectives
- Recognise clinical manifestations of PAD
- Be able to categorise patients according to their symptoms
- Know the indications/contraindications for treatment
- Understand the range of treatment strategies including medical, endovascular/interventional and surgical alternatives sufficiently to discuss management with patients and formulate appropriate treatment plans
- To learn how to treat iliac lesions, lesions of the aorta, and aorto-iliac lesions including obstructions
- Get familiar with the different stent types, balloon types and devices used for recanalisation
- To learn the results and complications and their prompt treatment options
Further information
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 2.2.1.1.1 Peripheral arterial disease.
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC). The CME accreditation for this course will expire on August 8, 2025. A non-CME accredited version of the course will remain available for two more years.
The acquired CME Certificate will be available in the myCIRSE area under CIRSE Academy.
The enrolment period of this course is linked to the validity of the All-Access Pass.
Release date: August 2023
